Блог

Why Your Stem Cells Slow Down After 40 (and What Science Is Doing About It)

Research shows MSC activity drops 40% by age 50. Learn what changes inside aging cells and three emerging therapies showing real results in 2026 clinical trials.

Sep 4, 2026

MSC Clinical Trials: What ISCT Dublin Revealed About Meniscal Repair, Mitochondrial Transfer, and Cell Sourcing

A medical review of MSC clinical trials 2026: key evidence from ISCT Dublin, a Japanese phase III synovial-MSC meniscal repair trial, bone marrow vs cord tissue OA data, and mitochondrial EV mechanisms.

Aug 28, 2026

Breathing Easier: How Stem Cell Therapy Is Changing COPD Treatment in Thailand

Our Bangkok clinic explores how MSC therapy is helping COPD patients breathe easier — reducing inflammation, reactivating lung stem cells, and improving quality of life.

Aug 28, 2026

Stem Cell Therapy for Spinal Cord Injury: What 2026 Research Tells Us About MSC Therapy After SCI

Japan approved the world’s first MSC therapy for spinal cord injury in 2018. Here’s what six years of real-world data and 2026 mechanism research tell us about where MSC therapy for SCI actually stands.

Aug 27, 2026

What Happens During Stem Cell Treatment Recovery Week in Bangkok?

Planning a trip to Bangkok for stem cell therapy involves more than just scheduling your procedure date. International patients need to know: What does the post-treatment recovery week actually look like? Whether receivi…

Aug 24, 2026

Stem Cell Therapy for Erectile Dysfunction: A Patient’s Guide to the 2026 Evidence

Diabetic ED, post-prostatectomy ED, PDE5 non-responders — here’s what 2026 trials and clinical experience show for stem cell therapy: who is a candidate, what the procedure looks like, what it costs, and what to expect.

Aug 22, 2026

Do Stem Cells Require Blood Type Matching? Biological Facts Explained

One of the most frequent clinical questions patients ask before undergoing regenerative treatment is whether receiving donor stem cells requires blood typing (ABO and Rh factor matching) or cross-matching, similar to a b…

Aug 21, 2026

MSC Therapy for Multiple Sclerosis: What 17 Trials and Tell Us

MSCs are the most promising cell therapy in progressive MS, and 2026 added the mechanism papers and one well-controlled trial that finally make the case. Here’s what 17 trials, SMART-MS, and the new miRNA work mean for r…

Aug 20, 2026

MSC-Derived Exosomes for Myocardial Infarction: Delivery Systems, Mechanisms, and the Bench-to-Bedside Pipeline

Eight 2026 studies detail how MSC exosomes inhibit ferroptosis, deliver sustained paracrine signaling via hydrogels, and improve LVEF in rat MI models. Here is what translational researchers need to know before the first…

Aug 20, 2026

Harnessing MSC-Derived Exosomes for Advanced Rheumatoid Arthritis Immunotherapy

Discover the groundbreaking potential of MSC-derived exosomes in revolutionizing Rheumatoid Arthritis immunotherapy. Learn about novel nanoplatforms and their mechanism of action.

Aug 19, 2026

MSC Therapy for Diabetic Foot Ulcers: 2026 Mechanism, Hydrogel Delivery, and Real-World Trial Outcomes

2026 medical update on MSC therapy for diabetic foot ulcers: M2 macrophage polarization, EXO-miR3671 angiogenesis, hydrogel delivery, UC-MSC vs ADSC head-to-head, 47-RCT meta-analysis, and cost-effectiveness vs amputatio…

Aug 18, 2026

Allogeneic vs Autologous Stem Cells: What 2026 Evidence Says Is Better

2026 Q3 update on allogeneic vs autologous MSC: head-to-head trial data, donor-age impact, 2026 manufacturing advances, when each is preferred, the cost picture, and FAQ for patients in Thailand and Asia-Pacific.

Aug 17, 2026

Page 1 of 13 — 147 posts